Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer

被引：10
作者：
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 12期
关键词：
OVARIAN-CANCER;
D O I：
10.1016/S1470-2045(18)30625-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1558 / 1560
页数：3
相关论文
共 50 条
[31]   Serum CA 125 Level after Neoadjuvant Chemotherapy is Predictive of Prognosis and Debulking Surgery Outcomes in Advanced Epithelial Ovarian Cancer [J].
Matsuhashi, Tomohiko ;
Takeshita, Toshiyuki ;
Yamamoto, Akihito ;
Kawase, Rieko ;
Yamada, Takashi ;
Kurose, Keisuke ;
Doi, Daisuke ;
Konnai, Katsuyuki ;
Onose, Ryo ;
Kato, Hisamori .
JOURNAL OF NIPPON MEDICAL SCHOOL, 2017, 84 (04) :170-176
[32]   The Effect of the Interval from the Third Cycle of Neoadjuvant Chemotherapy to Interval Debulking Surgery on the Surgical Results in Advanced Epithelial Ovarian Cancer [J].
Mahmoud Hanafy Meleis ;
Ahmed Mohammed Samy El-Agwany .
Indian Journal of Gynecologic Oncology, 2016, 14 (1)
[33]   Prognostic impact of microscopic residual disease after neoadjuvant chemotherapy in patients undergoing interval debulking surgery for advanced ovarian cancer [J].
Di Donato, Violante ;
Caruso, Giuseppe ;
Golia D'Auge, Tullio ;
Perniola, Giorgia ;
Palaia, Innocenza ;
Tomao, Federica ;
Muzii, Ludovico ;
Pernazza, Angelina ;
Della Rocca, Carlo ;
Bogani, Giorgio ;
Panici, Pierluigi Benedetti ;
Giannini, Andrea .
ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2025, 311 (02) :429-436
[34]   The Effect of the Interval from the Third Cycle of Neoadjuvant Chemotherapy to Interval Debulking Surgery on the Surgical Results in Advanced Epithelial Ovarian Cancer [J].
Meleis, Mahmoud Hanafy ;
El-Agwany, Ahmed Mohammed Samy .
INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY, 2016, 14 (01)
[35]   Impact of Ki-67 Labeling Index on Prognostic Significance of the Chemotherapy Response Score in Women With Tubo-ovarian Cancer Treated With Neoadjuvant Chemotherapy [J].
Heayn, Michelle ;
Skvarca, Lauren B. ;
Zhu, Li ;
Edwards, Robert P. ;
Olawaiye, Alexander B. ;
Modugno, Francesmary ;
Elishaev, Esther ;
Bhargava, Rohit .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (03) :278-285
[36]   Tubo-ovarian abscess mimicking ovarian cancer: A rare entity [J].
Villalon-Lopez, Jose Sebastian ;
Chavez-Gonzalez, Bruno .
GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (02) :128-133
[37]   Histological regression of peritoneal metastases of recurrent tubo-ovarian cancer after systemic chemotherapy [J].
Pache, Basile ;
Farinha, Hugo Teixeira ;
Toussaint, Laura ;
Demartines, Nicolas ;
Hastir, Delfyne ;
Mathevet, Patrice ;
Sempoux, Christine ;
Huebner, Martin .
FRONTIERS IN SURGERY, 2022, 9
[38]   Cost-Effectiveness of Neoadjuvant Chemotherapy versus Primary Surgery in Elderly Patients with Advanced Ovarian Cancer [J].
Poonawalla, Insiya B. ;
Lairson, David R. ;
Chan, Wenyaw ;
Piller, Linda B. ;
Du, Xianglin L. .
VALUE IN HEALTH, 2015, 18 (04) :387-395
[39]   Classification and morbidity of debulking surgery for advanced ovarian cancer [J].
Vincens, E. ;
Lauratet, B. ;
Lefranc, J. -P. .
BULLETIN DU CANCER, 2010, 97 (01) :73-77
[40]   Current and Emerging Strategies for Tubo-Ovarian Cancer Diagnostics [J].
Brincat, Mark R. ;
Mira, Ana Rita ;
Lawrence, Alexandra .
DIAGNOSTICS, 2023, 13 (21)
12345